Management of cytomegalovirus infection in lung transplant recipients : Evidence-based recommendations

Cytomegalovirus (CMV) continues to cause significant morbidity and mortality in lung transplant recipients. This article presents recommendations based on available evidence for the optimal management of CMV in lung transplant recipients, which have been developed by an expert committee of transplan...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Transplantation 2005-07, Vol.80 (2), p.157-163
Hauptverfasser:	ZAMORA, Martin R, DAVIS, R. Duane, LEONARD, Calm
Format:	Artikel
Sprache:	eng
Schlagworte:	Antiviral Agents - administration & dosage Antiviral Agents - therapeutic use Biological and medical sciences Cytomegalovirus Cytomegalovirus Infections - prevention & control Drug Administration Schedule Evidence-Based Medicine - standards Fundamental and applied biological sciences. Psychology Fundamental immunology Ganciclovir - administration & dosage Ganciclovir - analogs & derivatives Ganciclovir - therapeutic use Humans Lung Transplantation - adverse effects Medical sciences Postoperative Complications - prevention & control Postoperative Complications - virology Quality Assurance, Health Care Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases Tissue, organ and graft immunology Valganciclovir
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Cytomegalovirus (CMV) continues to cause significant morbidity and mortality in lung transplant recipients. This article presents recommendations based on available evidence for the optimal management of CMV in lung transplant recipients, which have been developed by an expert committee of transplant physicians-surgeons and infectious disease specialists.
ISSN:	0041-1337
DOI:	10.1097/01.TP.0000165430.65645.4F